News

Currently, the company is carrying out a multicenter, randomized, placebo-controlled Phase II clinical trial to evaluate the efficacy and safety of SER-109 in prevention of recurrent CDI. The

InSite is seeking marketing approval of BromSite in the United States. In its confirmatory Phase 3 clinical trials, BromSite achieved statistically significant superiority to vehicle in alleviating ocular

The amendment enhances MPP’s current licence by allowing South African manufacturers to join Indian and Chinese companies in developing generics for low- and middle-income countries. "We welcome the

The Phase 3 clinical trial program, known as COGNITIV SZ, is designed to assess the safety and efficacy of encenicline compared to placebo as a pro-cognitive therapy in

The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being

Under the agreement, Abbott will offer its HIV viral load tests – which monitor the amount of HIV in a person’s blood – at reduced prices to help

The deal, facilitated by J&J Innovation, will see the two firms jointly develop and commercialize RNA-based drug products to treat specified diseases using Arcturus’ UNA Oligomer chemistry and

PADAC has recommended the drug through a unanimous voting of 14 to zero, supporting the biologics licence application (BLA) for mepolizumab as an add-on maintenance treatment for severe

Around 60 individuals will be included in this multi-center, randomized, double-blind, placebo-controlled, two arm, parallel group Phase II trial of ADS-5102. During the trial, all patients will be